Synageva BioPharma beats by $0.03, misses on revenues

|About: Synageva BioPharma Corp. (GEVA)|By:, SA News Editor

Synageva BioPharma (GEVA): Q1 EPS of -$1.16 beats by $0.03.

Revenue of $1.6M misses by $0.2M.